Eligibility, any sex, with Distal Radius Fracture or Distal Ulna Fracture. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Fracture Healing Based on Clinical Measures and X-raysPrimary· Mean time of 3.8 years after the surgery
Fracture healing will be evaluated by x-rays and clinical measures (no pain at fracture site)
X-ray Evaluation
Group
Value
95% CI
DVR Plating System
103
DVR Plating System
2
DVR Plating System
10
Clinical Evaluation
Group
Value
95% CI
DVR Plating System
114
DVR Plating System
0
DVR Plating System
1
Product Safety Based on ComplicationsSecondary· Mean time of 3.8 years after surgery
Safety will be assessed by recording and analyzing the incidence and frequency of complications. The complications are classified per ISO 14155 Definitions: Adverse Events (AEs), Serious Adverse Events (SAEs), Adverse Device Effects (ADEs), Serious Adverse Device Effects (SADEs).
.
Adverse Events (AEs)
Group
Value
95% CI
DVR Plating System
77
Serious Adverse Events (SAEs)
Group
Value
95% CI
DVR Plating System
4
Adverse Device Effects (ADEs)
Group
Value
95% CI
DVR Plating System
11
Serious Adverse Device Effects (SADEs)
Group
Value
95% CI
DVR Plating System
0
Patient's Outcomes Were Also AssessedSecondary· Mean time of 3.8 years after surgery
Patients were asked to complete a patient questionnaire (Patient-Rated Wrist Evaluation Score- PRWE)\* and a question on their wrist function\*\*
\* the PRWE is a self-administered, patient-specific questionnaire that consists of 15 items. It was designed to measure wrist pain and disability in activities of daily living, and consists of two subscales: pain and function. A score of 100 represents the worst functional score, whereas 0 represents no disability
\*\* Patient reported outcome: assessment of fractured wrist comparing to before injury on a scale from 0 to 10, 0 being worst imaginab
PRWE Score
Group
Value
95% CI
DVR Plating System
12.8
± 17.9
General Wrist Function
Group
Value
95% CI
DVR Plating System
8.0
± 2.1
Adverse events — posted to ClinicalTrials.gov
Time frame: Reported Adverse Events (AEs) include events from the date each subject was implanted up to 3.8 years after surgery, when the last follow-up was performed and patients completed the study..
Reporting threshold: 0%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
111 Subjects Received DVR Plating System With a Mean Follow-up of 3.8 Years
The study is a single-center, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to confirm safety, performance and clinical benefits of the DVR Plates. The primary objective is the assessment of performance by analyzing fracture healing. The secondary objective is the assessment of safety by recording and analyzing the incidence and frequency of complications and adverse events. Patients' outcomes will also be assessed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other recruiting trials for Distal Radius Fracture
Currently open trials in the same condition.
NCT07291505 — The Investigation of Kinesiophobia in Conservative Distal Radius Fractures
· recruiting
NCT07042139 — No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older
· NA
· recruiting
NCT07426926 — Home-Based Photobiomodulation Effects in the Postoperative Period of Distal Radius Fractures
· NA
· recruiting
NCT06769373 — The Effects of Whirlpool and Contrast Bath in Patients with Complex Regional Pain Syndrome After Distal Radius Fracture
· NA
· recruiting
NCT07162142 — Retrograde Elastic Nailing With Pollar K-wire in Metaphyseal Diaphyseal Fracture of Distal Radius in Pediatric Patients
· NA
· active not recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zimmer Biomet
Last refreshed: 20 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04653051.